Iti Pharma And Healthcare Fund Overview | ||||||
---|---|---|---|---|---|---|
Category | Sectoral/ Thematic | |||||
BMSMONEY | Rank | 5 | ||||
Rating | ||||||
Growth Option 07-03-2025 | ||||||
NAV | ₹15.03(R) | -0.08% | ₹16.09(D) | -0.07% | ||
Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
Lumpsum | Regular | 11.9% | 19.07% | -% | -% | -% |
Direct | 14.01% | 21.51% | -% | -% | -% | |
Benchmark | ||||||
SIP (XIRR) | Regular | -3.82% | 19.99% | -% | -% | -% |
Direct | -1.91% | 22.42% | -% | -% | -% | |
Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
0.6 | 0.3 | 0.65 | 5.89% | 0.11 | ||
Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
16.14% | -24.78% | -16.32% | 0.87 | 11.67% |
NAV Date: 07-03-2025
Scheme Name | NAV | Rupee Change | Percent Change |
---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option | 15.03 |
-0.0100
|
-0.0800%
|
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 15.03 |
-0.0100
|
-0.0800%
|
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | 16.09 |
-0.0100
|
-0.0700%
|
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option | 16.09 |
-0.0100
|
-0.0700%
|
Review Date: 07-03-2025
ITI Pharma and Healthcare Fund has shown very good performance in the Sectoral/ Thematic Fund category. The fund has rank of 3 out of 20 funds in the category. The fund has delivered return of 11.9% in 1 year and 19.07% in 3 years. The category average for the same periods is 2.42% and 16.74% respectively, which shows poor return performance of fund in the category. The fund has exhibited standard deviation of 16.14, VaR of -24.78, Average Drawdown of -8.38, Semi Deviation of 11.67 and Max Drawdown of -16.32. The category average for the same parameters is 14.88, -19.83, -7.18, 10.65 and -17.78 respectively. The fund has high risk in the category.Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
Date | Iti Pharma And Healthcare Fund NAV Regular Growth | Iti Pharma And Healthcare Fund NAV Direct Growth |
---|---|---|
07-03-2025 | 15.0273 | 16.0886 |
06-03-2025 | 15.0388 | 16.1001 |
05-03-2025 | 14.9066 | 15.9578 |
04-03-2025 | 14.6482 | 15.6804 |
03-03-2025 | 14.552 | 15.5766 |
28-02-2025 | 14.584 | 15.6084 |
27-02-2025 | 14.8459 | 15.8879 |
25-02-2025 | 14.9994 | 16.0506 |
24-02-2025 | 15.0064 | 16.0572 |
21-02-2025 | 15.081 | 16.1345 |
20-02-2025 | 15.2884 | 16.3556 |
19-02-2025 | 15.1605 | 16.218 |
18-02-2025 | 15.1127 | 16.166 |
17-02-2025 | 15.1999 | 16.2584 |
14-02-2025 | 15.072 | 16.1191 |
13-02-2025 | 15.5085 | 16.585 |
12-02-2025 | 15.4165 | 16.4859 |
11-02-2025 | 15.5032 | 16.5777 |
10-02-2025 | 15.9618 | 17.0672 |
07-02-2025 | 16.3323 | 17.4607 |
Fund Launch Date: 17/Nov/2021 |
Fund Category: Sectoral/ Thematic |
Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved. |
Fund Description: An open ended equity scheme investing in Pharma and Healthcare |
Fund Benchmark: Nifty Healthcare Total Return Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.